查詢結果分析
相關文獻
- Evaluation of the Pain-Relieving Effect of Carbamazepine (Tegretol[feb9]) during Panretinal Photocoagulation
- 以focal ERG評估非增殖性糖尿病視網膜病變的中心凹變化
- Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Levels in the Vitreous of Patients with Proliferative Diabetic Retinopathy
- Long-Term Outcome of Vitreous Surgery for Proliferative Diabetic Retinopathy
- 使用雙眼間接眼底鏡雷射系統執行全網膜雷射
- 眼內新生血管疾病之新治療
- 糖尿病網膜病變
- 糖尿病視網膜病變:綜論及治療新趨勢
- Bevacizumab Pretreatment in Vitrectomy for Severe Proliferative Diabetic Retinopathy
- 糖尿病視網膜病變
頁籤選單縮合
題名 | Evaluation of the Pain-Relieving Effect of Carbamazepine (Tegretol[feb9]) during Panretinal Photocoagulation=以Carbamazepine (Tegretol[feb9])減輕全網膜雷射病人疼痛之治療評估 |
---|---|
作者 | 蔡宜佑; 林千琳; 楊寧廷; Tsai, Yi-yu; Lin, Chien-lin; Yang, Ning-ting; |
期刊 | 中臺灣醫學科學雜誌 |
出版日期 | 19980900 |
卷期 | 3:3 1998.09[民87.09] |
頁次 | 頁129-132 |
分類號 | 416.746 |
語文 | eng |
關鍵詞 | 增殖性糖尿病視網膜病變; 全網膜雷射; Proliferative diabetic retinopathy; Panretinal photocoagulation; Carbamazepine(Tegretol[feb9]); |
中文摘要 | 糖尿病患在接受全網膜雷射治療過程中常有疼痛不適的感覺,甚至有因劇烈疼痛而無法順利完成全網膜雷射治療。本篇搜集32位患有增殖性糖尿病視網膜病變之病患,在其雷射治療前,隨機給予carbamazepine(Tegretol�飽^口服作為治療組, 而給予placebo口服作為對照組,在雷射治療後以visual analogue scale(VAS)來評估病人疼痛感受程度,治療組之VAS平均分數為31.2 ± 2.5,對照組為45.3 ± 2.5,用Student's paired t-test分析發現接受carbamazepine治療者,其因雷射治療引起的疼痛相較於對照組有明顯差異的緩解,顯示對於接受網膜雷射治療過程中感覺疼痛而引以為苦的病人,治療前單次給予口服carbamazepine 200mg,可以作為一種有效減少病人疼痛的選擇方式。 |
英文摘要 | Panretinal photocogulation (PRP) is necessary for patients with proliferative diabetic retinopathy. The therapy, however, is discomfortable to patients, sometimes too painful to patients. Clinically, conventional analgesics (e.g. NSAID) cannot relieve the pain completely. To evaluate the pain-relieving effect of carbamazepine (Tegretol��)during PRP, 32 patients of proliferative diabetic retinopathy were enrolled in the study. They were randomly allocated to a drug therapy group, which received carbamazepine in a dose of 200mg one hour before laser treatment, or to a control group, which received one tablet of placebo. The degree of pain was measured by visual analogue scale (VAS) under a double blind method. The average VAS scores of the drug therapy group was 32.2±2.5, while the control group was 45.3±2.5. Our results demonstrated that a dose of 200 mg carbamazepine before PRP could achieve considerable pain relief. The pain relief given by carbamazepine was superior to that provided by the placebo and can be considered to offer a very effective means of treating neuralgia induced by PRP. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。